Allianz Asset Management
WST icon

Allianz Asset Management’s West Pharmaceutical WST Stock Holding History

Allianz Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-600
Closed -$281K – 2684
2021
Q4 		$281K Buy
+600
New +$258K ﹤0.01% 2395

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allianz Asset Management's WST Position: Q1 2026 in Review

Allianz Asset Management increased its West Pharmaceutical (WST) stake by 628% in Q1 2026, buying an estimated $37.9M and bringing the position to 176,560 shares worth $44.3M. The position accounts for 0.05% of the portfolio, ranked #361.

Allianz Asset Management first reported a position in WST in Q2 2013 and has held it in 47 quarters since. The position peaked at $75.5M in Q1 2024. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Allianz Asset Management held 176,560 shares of West Pharmaceutical worth $44.3M as of Q1 2026.
  • Allianz Asset Management bought 152,310 West Pharmaceutical shares in Q1 2026, an estimated $37.9M.
  • West Pharmaceutical made up 0.05% of Allianz Asset Management's portfolio in Q1 2026, its #361 holding.
  • Allianz Asset Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 47 quarters since.
  • Allianz Asset Management's West Pharmaceutical position peaked at $75.5M in Q1 2024.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.